INCE Capital — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
UXLINK is a Web3 social platform and infrastructure that connects users and projects through account abstraction and cross-chain functionality.
Crypto & Web3Developer ToolsSocialTokyo, JP
Co-investorsHashkey CapitalHongShan Capital GroupKuCoin LabsManifoldManifold VenturesOKX Ventures+2 more
Avenzo Therapeutics is a clinical-stage biopharmaceutical company developing therapeutic treatments.
BiotechSan Diego, US
Athena Countouriotis(Co-Founder, Chief Executive Officer)Mohammad Hirmand(Executive Officer)inPaolo Tombesi(Executive Officer)inScott Lipman(Executive Officer)inBrian Sun(Executive Officer)in
BoardCarl Gordon(Director)
Co-investorsDelos CapitalForesite CapitalLongwood FundNew Enterprise Associates (NEA)OrbiMedQuan Capital+6 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.











